Evidence map›Paper›PMID 16463210›Full record

GuidelineJournal of hepato-biliary-pancreatic surgery2006

JPN Guidelines for the management of acute pancreatitis: medical management of acute pancreatitis.

Kazunori Takeda, Tadahiro Takada, Yoshifumi Kawarada, Koichi Hirata, Toshihiko Mayumi, Masahiro Yoshida, Miho Sekimoto, Masahiko Hirota, Yasutoshi Kimura, Shuji Isaji and 4 more

Open access · bronzeAbstract readPractice Guideline
In one paragraph

Guideline in Journal of hepato-biliary-pancreatic surgery, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 4 pooled it
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 4 syntheses or guidelines pooled it, 114 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Review
  10. Review
  11. Association of asparaginase-associated pancreatitis and ULK2 gene polymorphism.International journal of clinical and experimental pathology · 2020
    Article
  12. Prophylactic antibiotics in acute pancreatitis: endless debate.Annals of the Royal College of Surgeons of England · 2017
    Article
  13. Review
  14. Review
  15. Article
  16. Study on acute recent stage pancreatitis.World journal of gastroenterology · 2014
    Review
  17. Treatment of severe acute pancreatitis and its complications.World journal of gastroenterology · 2014
    Review
  18. Article
  19. Management of severe acute pancreatitis.The Indian journal of surgery · 2012
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 11 institutions in 1 country.

Kazunori TakedaDepartment of Surgery, National Hospital Organization Sendai Medical Center, Miyagino-ku, Sendai 983-8520, Japan.
Tadahiro Takada
Yoshifumi Kawarada
Koichi Hirata
Toshihiko Mayumi
Masahiro Yoshida
Miho Sekimoto
Masahiko Hirota
Yasutoshi Kimura
Shuji Isaji
Masaru Koizumi
Makoto Otsuki
Seiki Matsuno
JPN
Sapporo Medical University · JPTeikyo University · JPFukushima Medical University Hospital · JPKumamoto University · JPKyoto University · JPMie University · JPNagoya University · JPOme Municipal General Hospital · JPSendai Medical Center · JPTohoku University · JPUniversity of Occupational and Environmental Health Japan · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The basic principles of the initial management of acute pancreatitis are adequate monitoring of vital signs, fluid replacement, correction of any electrolyte imbalance, nutritional support, and the prevention of local and systemic complications. Patients with severe acute pancreatitis should be transferred to a medical facility where adequate monitoring and intensive medical care are available. Strict cardiovascular and respiratory monitoring is mandatory for maintaining the cardiopulmonary system in patients with severe acute pancreatitis. Maximum fluid replacement is needed to stabilize the cardiovascular system. Prophylactic antibiotic administration is recommended to prevent infectious complications in patients with necrotizing pancreatitis. Although the efficacy of the intravenous administration of protease inhibitors is still a matter of controversy, there is a consensus in Japan that a large dose of a synthetic protease inhibitor should be given to patients with severe acute pancreatitis in order to prevent organ failure and other complications. Enteral feeding is superior to parenteral nutrition when it comes to the nutritional support of patients with severe acute pancreatitis. The JPN Guidelines recommend, as optional measures, blood purification therapy and continuous regional arterial infusion of a protease inhibitor and antibiotics, depending on the patient's condition.

Indexed as

Acute DiseaseAnalgesiaAnti-Bacterial AgentsFluid TherapyHemodiafiltrationHumansJapanMonitoring, PhysiologicNutritional SupportPancreatitisProtease InhibitorsAnti-Bacterial AgentsProtease Inhibitors

Identifiers

PMID16463210
PMCPMC2779395
OpenAlexW2076008787

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.